Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsNeuroQuant MS

Vendor source

Reviewed 11 May 2026

Completeness Strong (78%)

NeuroQuant MS

Cortechs.ai

NeuorQuant MS is an automated imaging software aimed at assisting physicians in their clinical evaluation process, treatment planning, and monitoring of neurodegenerative diseases by combining T2 FLAIR with 3D T1 scans for lesion and structure quantification. It automatically segments, counts, and visualizes lesions, and quantifies lesion volume changes and brain volume changes.

No papers to support — we monitor for new evidence.

NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS
NeuroQuant MS thumbnail 1
NeuroQuant MS thumbnail 2
NeuroQuant MS thumbnail 3
NeuroQuant MS thumbnail 4
NeuroQuant MS thumbnail 5
NeuroQuant MS thumbnail 6
NeuroQuant MS thumbnail 7
NeuroQuant MS thumbnail 8
NeuroQuant MS thumbnail 9
NeuroQuant MS thumbnail 10
NeuroQuant MS thumbnail 11

Key Features

  • And shrinking lesions
  • Enlarging
  • Lesion burden calculation
  • Lesion change summary
  • Lesion counts and volumes for new
  • Longitudinal change data for lesions (per region) and brain structures
  • Normative data comparisons
  • Stable

General Information

Product name

NeuroQuant MS

Modality

MR

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Multiple Sclerosis (MS), neurodegenerative diseases

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class IIa

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

Technical Specifications

Patient population age

Not specified

Input

3D T1 MR sequence, 3D or 2D T2 MR sequence

Input format

DICOM

Output

Lesion and brain structure segmentation overlays, lesion and brain change overlays, quantitative report with volumetric results

Output format

DICOM

Integration

Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

On demand, triggered by a user through e.g. a button click, image upload

Processing time

> 10 minutes

Population

All MR series where lesions are suspected

Market Presence

On market since

08-2006

AI Platforms

Resellers

Getz Healthcare, GMP, Olea Medical

Countries present

43

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Number of analyses, Number of installations

Source: Vendor | First published: May 7, 2021 | Last updated: May 11, 2026